AbbVie | ABBV - Market Capitalization

Stock Price
208.61
Daily Change
-3.95 -1.86%
Monthly
5.02%
Yearly
6.30%
Q3 Forecast
210.80

AbbVie reported $371.58B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.




Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Abbott USD 236.64B 6.58B Jun/2025
ALKERMES USD 4.72B 725M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Neurocrine Biosciences USD 12.44B 1.5B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Pacira USD 1.11B 43M Jun/2025
Perrigo USD 3.65B 177M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025
Ultragenyx Pharmaceutical USD 3.44B 38M Jun/2025
United Therapeutics USD 12.96B 934M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025
Zoetis USD 69.43B 4.01B Jun/2025